Clinical trial
Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty: a Double Blind, Non-inferiority Study
NCT06317870 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Vaudois as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty: a Double Blind, Non-inferiority Study
- Lead sponsor
- Centre Hospitalier Universitaire Vaudois
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 10, 2024
- Completion date
- May 1, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia, hip arthropathy, post operative pain